about
Risk assessment in the prevention of cardiovascular disease in low-resource settingsStem Cell Therapy for the Heart: Blind Alley or Magic Bullet?Top 100 cited articles in cardiovascular magnetic resonance: a bibliometric analysisNon-communicable diseases (NCDs) in developing countries: a symposium report.Cardiovascular risk in women attending primary care centres: baseline data of the EVA study.Global perspective on acute coronary syndrome: a burden on the young and poor.Cardiovascular disease research in Latin America: a comparative bibliometric analysisCardiovascular disease risk prevention: preliminary survey of baseline knowledge, attitude and practices of a nigerian rural community.Acute coronary eventsEffects of Long-Term Statin Therapy in Coronary Artery Disease Patients with or without Chronic Kidney Disease.Wide Variation in Absolute Cardiovascular Risk Assessment in Aboriginal and Torres Strait Islander People with Type 2 DiabetesCardiovascular defense challenges at the basic, clinical, and population levelsMolecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Influence and predicting variables of obstructive sleep apnea on cardiac function and remodeling in patients without congestive heart failure.From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020.Dietary Nitrate, Nitric Oxide, and Cardiovascular Health.Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?Taking cardiac surgery to the people.Effect of 7-difluoromethyl-5, 4'-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(-/-) mice induced by a cholesterol-rich diet.Dietary intake and prospective changes in cardiometabolic risk factors in children and youth.Improving cardiovascular health in women & children around the world.Vascular calcification, diabetes, and cardiovascular disease: connecting the dots.The time has come for clinical cardiovascular trials with plaque characterization as an endpoint.Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: Systematic review with meta-synthesis of quantitative and qualitative data.Sleep Quality, Sleep Duration, and the Risk of Coronary Heart Disease: A Prospective Cohort Study With 60,586 Adults.Adherence to Treatment in Hypertension.Mutation Analysis of the Mitochondrial tRNA Genes in Iranian Coronary Atherosclerosis Patients.Can we dramatically reduce the incidence of coronary heart disease?
P2860
Q26744435-081C1954-A7E9-4E82-B906-B618918B1F98Q28069300-4B365220-73DF-4F97-A0B0-DC6FD8AA75D8Q28075811-AC587FB5-65BE-4988-9D34-87022C9393ADQ30389985-32924349-7C95-4C74-AC69-708D8E2B1ED7Q30582667-0A92DE9A-FCB9-4D81-9D5C-D045A505DA55Q34088547-57A6D932-3336-4841-8E9F-45AEED3F058DQ34117970-D102186E-EA93-4061-812D-6671D5AD8BC6Q34320368-6AB00698-8F99-4FB4-B59E-44516B860677Q35878289-75A67936-789C-4E2E-BDCA-AC1516A8D1A9Q36199235-65DF45C2-DDAC-49FF-8F1C-4F2E4472156DQ36661019-06A3BF60-3BE9-457F-995D-79B77D7B18D1Q37118290-90F14AB3-2946-4900-8794-86C4F45979D5Q37254899-AD454D7E-69E7-4389-90A0-97613971697CQ37405844-0AECC7CB-5BBC-4F04-B394-5ABF2E7C1048Q37928904-B81F9D6B-BDAD-4501-B319-8777E1F4D9B9Q38481409-6A9DF088-E723-4ACE-B6A4-5AC3C93222D2Q38763352-DC542D4E-2E86-42AF-B235-982EF01939E6Q39609722-9E8D119B-42AC-4279-9281-9F7CF2572224Q39744497-02EDE8EB-226E-4B2C-98A9-37623EDF576AQ40427455-996B2718-06B4-4865-A305-5E9211EC4466Q42373072-85E157B2-E806-4B55-92FA-C19EA1F8543BQ42546038-F5CE5244-2A01-4AE4-A0FB-55BB6DF0EF47Q43055711-EDA60F48-7E40-488E-A4DB-042D2799B692Q47192608-9CCBC415-997E-43C6-BE30-2EFE1675CE93Q47548155-864C3F78-7B63-4133-892A-174DD4F1B57CQ48967636-0518DC1F-800D-4E68-8BB5-2A260E588FB1Q49188878-36F0C26D-AE5F-4BF6-95D2-9D4C899F81BFQ56986316-3ABC59B1-C2AB-4580-8BE1-626D99FC44CE
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Promoting global cardiovascular health: moving forward.
@ast
Promoting global cardiovascular health: moving forward.
@en
Promoting global cardiovascular health: moving forward.
@nl
type
label
Promoting global cardiovascular health: moving forward.
@ast
Promoting global cardiovascular health: moving forward.
@en
Promoting global cardiovascular health: moving forward.
@nl
prefLabel
Promoting global cardiovascular health: moving forward.
@ast
Promoting global cardiovascular health: moving forward.
@en
Promoting global cardiovascular health: moving forward.
@nl
P2093
P1433
P1476
Promoting global cardiovascular health: moving forward.
@en
P2093
Bridget B Kelly
Rajesh Vedanthan
Valentin Fuster
P304
P356
10.1161/CIRCULATIONAHA.110.009522
P407
P577
2011-04-01T00:00:00Z